The main product of the company is neomycin sulfate, such kind of product belongs to aminoglycosides antibiotic drugs, it is an animal broad-spectrum antibiotic, its downstream finished drugs have good prevention and treatment functions to the various germs, especially for the alimentary canal and respiratory system of the animal.

The company integrates technological superiority, raw material advantage and geographical advantage, and has incontrovertible dominant right and pricing power to such product, the company's sales network has covered the global market, the main plate is: Asia, Europe, Africa, South America and North America, spreading to each region and country with each continent as center. Firstly, the products in our company have mainly covered East Asia and Southeast Asia region, such as, China, India, Pakistan, Philippines and other places", and European market: Western Europe and Central Europe, such as, England, Holland and the like, in West Africa, North Africa, West Africa and Central Africa have been covered. In North America and South America, America, Canada and other countries have been covered. What is mentioned above are the sales core plates of the company and main pharmacy areas in each extending country, such as, for foreign trade, the district or continent of the large-size farm is regarded as the important sales area in US and UK. Such as, for domestic trade, the large animal husbandry province is regarded as the important sales area in China, such as: Henan province, Shandong province, Guangdong province, the Nei Monggol Autonomous Region, Xinjiang Province, Hubei Province, Hebei province and the like.